| Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy C Karacin, T Eren, E Zeynelgil, GI Imamoglu, M Altinbas, I Karadag, ... Future Oncology 17 (33), 4447-4456, 2021 | 39 | 2021 |
| Investigation of Clinical Features and the Use of Complementary and Alternative Medicines in Cancer Patients, A Single-Center Experience. T Eren, Gİ İmamoğlu, C Karaçin, E Zeynelgil, H Şahinli, E Cilbir, ... Acta Oncologica Turcica 52 (3), 455-462, 2019 | 2 | 2019 |
| Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases Z Oruç, MA Kaplan, M Karaağaç, N Özyurt, AM Tatlı, AO Kaya, S Menekşe, ... Future Oncology 17 (13), 1611-1624, 2021 | 1 | 2021 |
| Küçük hücreli akciğer kanserinde (KHAK) prognostik parametre olarak nötrofil, lenfosit, LDH ve NLO değerleri ile NLO’nun sağkalıma etkisi M Altınbaş, C Karaçin, NPÇ Yılmaz, B Gülden, E Zeynelgil, Gİ İmamoğlu Uluslararası Modern Sağlık Bilimleri Dergisi 1 (1), 1-4, 2020 | 1 | 2020 |
| Efficacy of systemic treatments in patients with metastatic lung invasive mucinous adenocarcinoma T Demir, M Araz, C Moloney, E Hendem, MZ Koçak, M Erman, O Baş, ... Clinical Lung Cancer, 2024 | | 2024 |
| Assessment Of Serum Cyanocobalamin Level And Importance In Patients With Hematological Malignancies E Zeynelgil, B Sağlam, M Asıl, Ö Doğan Turkish Journal of Clinics and Laboratory 14 (2), 270-273, 2023 | | 2023 |
| Prognostic Significance of Mean Platelet Volume to Lymphocyte Ratio in Patients with Metastatic Colon Cancer H Şahinli, E Zeynelgil, à Doğan, Tà Eren, M Altınbaş, S Türker Biomedical Journal of Scientific & Technical Research 37 (3), 29434-29440, 2021 | | 2021 |
| The Prognostic Value of the Red Cell Distribution Width to Platelet Count Ratio in Patients with Breast Cancer H Şahinli, E Zeynelgil, S Türker Türkiye Klinikleri. Tip Bilimleri Dergisi 40 (2), 188-195, 2020 | | 2020 |
| Meme kanserli hastalarda kırmızı küre dağılım genişliğinin trombosit sayısına oranının prognostik değeri H Şahinli, E Zeynelgil, S Türker Turkiye Klinikleri Journal of Medical Sciences 40 (2), 188-195, 2020 | | 2020 |
| Small Cell Lung Cancer With Brain Metastases Under Long-Term Primary Control PP Esra ZEYNELGİL , Özlem Aydın İSAK Uluslararası Modern Sağlık Bilimleri Dergisi 1 (2), 36-38, 2020 | | 2020 |
| The effect of neutrophil, lymphocyte, LDH and NLO on overall survival as a prognostic parameter in small cell lung cancer (SCLC) Gİİ Mustafa ALTINBAŞ, Cengiz KARAÇİN, Niğmet Pelin Çavdar YILMAZ , Betül ... Uluslararası Modern Sağlık Bilimleri Dergisi 1 (1), 2020 | | 2020 |
| A new prognostic index in patients with hormone receptor-positive and HER2-negative breast cancer. H Şahinli, E Zeynelgil, S Turker, D Yazilitaş, OA İshak, M Altinbaş Current Gynecologic Oncology 17 (4), 2019 | | 2019 |
| Mean platelet volume to lymphocyte ratio as a novel marker in patients with breast cancer who underwent curative resection. H Şahinli, E Zeynelgil, S Türker, M Altınbaş Current Gynecologic Oncology 17 (3), 2019 | | 2019 |
| Nowy wskaźnik prognostyczny u pacjentek z rakiem piersi i ekspresja receptorów hormonalnych oraz brakiem ekspresji HER2 H Şahinli, E Zeynelgil, S Türker, D Yazilitaş, Ö Ishak, M Altinbas Current Gynecologic Oncology 17 (4), 164-167, 2019 | | 2019 |
| Stosunek sredniej objȩtosci plytek krwi do liczby limfocytów jako nowy marker u chorych na raka piersi po pierwotnym zabiegu operacyjnym H Şahinli, E Zeynelgil, S Türker, M Altinbaş Current Gynecologic Oncology 17 (3), 118-122, 2019 | | 2019 |
| Hematolojik malignitesi olan hastalarda serum siyanokobalamin düzeyi ve öneminin değerlendirilmesi E Zeynelgil Necmettin Erbakan Üniversitesi Meram Tıp Fakültesi, 2016 | | 2016 |
| Kanser Hastalarında Tamamlayıcı ve Alternatif Tedavi Kullanımı İle Klinik Özelliklerin İncelenmesi, Tek Merkez Deneyimi. T Eren, Gİ İmamoğlu, C Karaçin, E Zeynelgil, H Şahinli, E Cilbir, ... ACTA ONCOLOGICA TURCICA 52 (3), 455-462, 0 | | |
| Investigation of Clinical Features and the Use of Complementary and Alternative Medicines in Cancer Patients, A Single-Center Experience KH Tamamlayıcı | | |
